Taiyun Pharmaceutical

Taiyun Pharmaceutical is a clinical-stage biopharmaceutical company based in China, dedicated to the discovery and development of innovative therapies for oncology and autoimmune diseases. The company focuses on high-potential targets such as EGFR and VEGFR, utilizing both small molecule and monoclonal antibody modalities. Taiyun's pipeline includes several candidates in various stages of clinical development, aimed at addressing significant unmet medical needs in the treatment of solid tumors and inflammatory conditions. By leveraging its internal R&D capabilities and strategic collaborations, Taiyun Pharmaceutical strives to deliver effective and accessible medicines to patients globally.